Showing results (271-280 of 1,068) with videos related to

Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|July 5, 2022
Exploring Inductive Linearization for simulation and estimation with an application to the Michaelis-Menten modelSepideh Sharif, Chihiro Hasegawa, Stephen B Duffull
Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2021
Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian womenWojciech Krzyzanski, Mark A Milad, Alan H Jobe, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 21, 2016
Physiologically-based pharmacokinetic models: approaches for enabling personalized medicineClara Hartmanshenn, Megerle Scherholz, Ioannis P Androulakis
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2017
Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic modelsVijay K Siripuram, Daniel F B Wright, Murray L Barclay, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 6, 2021
Machine learning-guided, big data-enabled, biomarker-based systems pharmacology: modeling the stochasticity of natural history and disease progressionMason McComb, Rachael Hageman Blair, Martin Lysy, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 23, 2022
Estimation of time to progression and post progression survival using joint modeling of summary level OS and PFS data with an ordinary differential equation modelMario Nagase, Sameer Doshi, Sandeep Dutta, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 5, 2023
Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019-2023) by US FDA, best practices and recommendationsAmitava Mitra, Jong Bong Lee, Douglas Steinbach, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 26, 2023
Physiologically based pharmacokinetic model to predict drug-drug interactions with the antibody-drug conjugate enfortumab vedotinMary P Choules, Peiying Zuo, Yukio Otsuka, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 20, 2023
Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc)Yanke Yu, Michael E Rothenberg, Han Ting Ding, et al.
Pageof 107